Pasithea Therapeutics Corp. Annual report pursuant to Section 13 and 15(d)

Warrants (Details) - Schedule of warrants exercisable	12 Months Ended
Warrants (Details) - Schedule of warrants exercisable	Dec. 31, 2022 $ / shares shares
Warrants (Details) - Schedule of warrants exercisable [Line Items]
Number of Warrants \| shares	15,356,000
Weighted-average remaining contractual term (years)	3 years 11 months 8 days
Weighted-average exercise price \| $ / shares	$ 4.12
1.88 [Member]
Warrants (Details) - Schedule of warrants exercisable [Line Items]
Exercise Price \| $ / shares	$ 1.88
Number of Warrants \| shares	2,000,000
Weighted-average remaining contractual term (years)	4 years 7 months 17 days
3.50 [Member]
Warrants (Details) - Schedule of warrants exercisable [Line Items]
Exercise Price \| $ / shares	$ 3.5
Number of Warrants \| shares	8,680,000
Weighted-average remaining contractual term (years)	3 years 10 months 24 days
6.00 [Member]
Warrants (Details) - Schedule of warrants exercisable [Line Items]
Exercise Price \| $ / shares	$ 6
Number of Warrants \| shares	276,000
Weighted-average remaining contractual term (years)	3 years 8 months 15 days
6.25 [Member]
Warrants (Details) - Schedule of warrants exercisable [Line Items]
Exercise Price \| $ / shares	$ 6.25
Number of Warrants \| shares	4,400,000
Weighted-average remaining contractual term (years)	3 years 8 months 15 days